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versus 2.1 ± 0.1, p = 0.05), and for the lesions with short stent length (18.6 ± 1.6 mm
versus 23.3 ± 1.4 mm, p = 0.04), with lipid-laden intima (88% versus 44%, p = 0.05),
thin-cap fibroatheroma (TCFA)-like intima (75% versus 31%, p = 0.04), and intimal
disruption (88% versus 27%, p < 0.01). A multiple logistic regression analysis
identified intimal disruption (odds ratio: 19.40, 95% confidence interval: 1.02 to
369.02; p = 0.049) as an independent risk factor for stent thrombosis. The lesions with
intimal disruption (n = 19) versus those without (n = 34) expressed a higher incidence
of ST (37% versus 3%, p = 0.002), lipid-laden intima (90% versus 29%, p < 0.0001),
and TCFA-like intima (84% versus 12%, p < 0.0001). Lesions with stent duration > 2
years (n = 30) versus the others (n = 23) raised the rates of cholesterol crystal (47%
versus 0%, p = 0.0001), calcified neointima (47% versus 4%, p = 0.0007), lipid-laden
intima (83% versus 9%, p < 0.0001), TCFA-like intima (60% versus 9%, p = 0.0001),
and intimal disruption (50% versus 17%, p = 0.01).
Conclusion: Long stent duration leads neointima to be atherosclerotic and disrupted
after bare-metal stenting. Late stent thrombosis might be associated with disrupted
neotissue.
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Background: We used virtual histology-intravascular ultrasound (VH-IVUS) to
evaluate the relation between coronary artery remodeling pattern and plaque
components in 1,133 patients.
Methods: We divided the patients into two groups according to the remodeling pattern
as positive remodeling (PR, remodeling index >1.05) (n=192) and intermediate
remodeling (IR, remodeling index ≤1.05 and >0.95)/negative remodeling (NR,
remodeling index <0.95) (n=941). VH-IVUS analysis classified the color-coded tissue
into four major components: green (fibrotic, FT); yellow-green (fibro-fatty); white
(dense calcium); and red (necrotic core, NC). Thin-cap fibroatheroma (TCFA) was
defined as focal, NC-rich (≥ 10% of the cross-sectional area) plaques being in contact
with the lumen in a plaque burden ≥ 40%.
Results: At the minimum lumen site, PR group had greater plaque plus media area
(12.8±4.9 vs. 9.9±3.8 mm2, p<0.001) and greater %NC area (21.7±12.3 vs.
18.2±11.6%, p<0.001) and smaller %FT area (57.0±14.5 vs. 59.4±14.6%, p=0.037)
compared with IR/NR group. PR group had greater plaque volume (188±150 vs.
135±130 mm3, p<0.001) and greater %NC volume (19.1±9.6 vs. 16.6±9.2%, p=0.001)
and smaller %FT volume (58.3±11.7 vs. 60.6±11.0%, p=0.009) compared with IR/NR
group. PR group had more TCFA compared with IR/NR group (21% vs. 13%,
p=0.006). Similar findings about plaque components were observed in terms of greater
%NC volume and smaller %FT volume in PR group compared with IR/NR group in
patients with both acute coronary syndrome and stable angina.
Conclusion: VH-IVUS analysis demonstrates that PR was associated with more
vulnerable plaque components compared with IR/NR regardless of their clinical
presentation.
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Background: Atherosclerotic plaques associated with acute coronary syndromes
(ACS) on histopathological characterisation demonstrate either ruptured fibrous caps
(RFC) or intact fibrous caps (IFC). The latter IFC lesions are often referred to as plaque
erosions and are responsible for up to one-third of culprit lesions in ACS patients.
Invasive and non-invasive imaging modalities including OCT, angioscopy, IVUS and
CT-angiography would be useful to disclose the mechanism of ACS.
Methods: While 57 patients with ACS or stable angina consented to multiple invasive
and noninvasive imaging procedures, 63 culprit lesions were evaluated by CT-
angiography, OCT, angioscopy and IVUS. Whilst intraluminal thrombus was assessed
by OCT or angioscopy, culprit lesions were classified further by OCT-based
demonstration of fibrous-cap integrity.
Results: Of 38 culprit lesions with ACS, OCT revealed IFC with thrombus (erosion)
in 11 (29%) and ruptured fibrous cap in the remaining 27 (71%); all 25 lesions with
stable angina had intact-fibrous caps. Fibrous caps were significantly thinner in RFC-
ACS than IFC-ACS and stable angina by OCT (45±12μm, 146±49μm, 321±134μm,
respectively; p=0.001). CT verified that low-attenuation plaques were more frequently
observed in RFC-ACS than IFC-ACS and stable angina (85, 36, 16%; p=0.001) lesions.
Similarly, positive remodelling was more predominantly seen in RFC-ACS than IFC-
ACS and stable angina (93, 18, 12%; p=0.001). However, none of the specific
CT-angiography features clearly distinguished IFC-ACS from stable lesions.
Conclusion: IFC-ACS lesions based on OCT and angioscopic characteristics
demonstrated less low attenuation plaque and less positive remodelling than ruptured
plaques by CT-angiography. Since there are no unique CT features of non-ruptured
culprit lesions to enable their clear distinction from stable lesions, it will be difficult
to develop CT-based non-invasive imaging techniques to allow the clear identification
of subjects at high risk of developing ACS due to plaque erosion.
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Background: Drug-eluting stents (DES) decrease the risk of restenosis by reducing
the neointimal response. However, DES may impair strut coverage and this has been
associated with late stent/scaffold thrombosis (ST). Bioresorbable vascular scaffolds
(BVS) may overcome the risk of ST when completely resorbed. It is unknown if, during
the bioresorption process the neointimal response of the everolimus-BVS (Absorb)
differs from that of the metallic everolimus-DES (Xience). The objective of the present
study is to compare the neointimal response of Xience and Absorb assessed by optical
coherence tomography (OCT) at 1 year.
Methods: A total of 31 and 19 lesions were treated with a single Absorb or Xience
scaffolds and imaged with OCT at 1 year. Patients with ST elevation myocardial
infarction, chronic total occlusions or requiring overlapped stents were excluded.
Neointimal response was assessed as: percentage of uncovered struts, neointimal
thickness (NIT), in-stent/scaffold area obstruction and pattern of neointima.
Results: No significant differences in the angiographic lumen loss were seen for the
Xience and Absorb (0.18±0.20 mm vs. 0.29±0.36 mm; p=0.42). OCT analysis of 951
cross-sections and 8385 struts demonstrated similar rates of uncovered struts (5.3%
Xience vs. 4.5% Absorb; p=0.11), mean NIT (120.6±46.0 μm vs. 136.1±71.4 μm;
p=0.82) and in-stent/scaffold area obstruction (12.5±7.1% vs. 13.6±9.7%; p=0.91),
respectively. There was a trend of higher heterogenic tissue pattern of neointima (21.1%
vs. 6.5%; p=0.12) and less intra-luminal masses (0% vs. 12.9%; p=0.10) with Xience
than Absorb.
Conclusion: The Absorb everolimus-BVS demonstrated a similar neointimal response
as the Xience everolimus-DES; and the risk of scaffold thrombosis is, with that respect,
expected to be comparable to the Xience in the first year. However, the presence of
intra-luminal masses at 12 months in a small proportion of patients warranted watchful
follow-up of these cases.
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Background: Intravascular ultrasound (IVUS) offers tomographic images of coronary
artery, helping physicians refine percutaneous coronary intervention (PCI) procedures.
However, it is still controversial whether routine use of IVUS in conventional lesions
leads to improvement in clinical outcomes after PCI.
Methods: From the EXCELLENT trial, patients were grouped into IVUS-guided
versus IVUS-non-guided PCI (619 and 802 patients, respectively). The crude
population as well as the propensity score matched pairs were compared with regard
to clinical outcome. Thirty-two baseline clinical and angiographic variables were used
for propensity scoring.
Results: Baseline characteristics showed younger age and lower incidence of
comorbidities in the IVUS-guided PCI group. In 463 matched pairs (926 patients),
baseline characteristics were better comparable between the IVUS-guided versus non-
guided groups. In terms of procedure profiles, IVUS-guided PCI was associated with
longer stenting length, larger stent diameter, and greater number of stents implanted.
In the total population, IVUS guidance was associated with a significantly higher risk
of periprocedural MI. There were no significant differences in other outcomes. In the
matched cohort, IVUS guidance was associated with significantly increased risk of
target lesion failure at 1 year (4.3% vs. 2.4%; p=0.047 by conditional logistic
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